LeMaitre Vascular Market Cap 2007-2019 | LMAT

LeMaitre Vascular market cap history and chart from 2007 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. LeMaitre Vascular market cap as of October 21, 2019 is $0.71B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.707B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $144.308B 26.34
Medtronic (MDT) Ireland $143.049B 20.08
Stryker (SYK) United States $80.458B 27.82
Boston Scientific (BSX) United States $53.838B 26.11
Baxter (BAX) United States $45.159B 27.38
EssilorLuxottica Societe Anonyme (ESLOY) France $32.445B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.251B 18.08
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.453B 0.00
Terumo (TRUMY) Japan $24.836B 31.00
Smith & Nephew SNATS (SNN) United Kingdom $19.091B 0.00
ResMed (RMD) United States $18.765B 35.76
Sunny Optical Technology (SNPTF) China $16.387B 0.00
Bio-Rad Laboratories (BIO) United States $10.297B 55.20
Insulet (PODD) United States $9.275B 549.57
Perrigo (PRGO) Ireland $7.335B 13.51
Canopy Growth (CGC) Canada $7.079B 0.00
Hill-Rom Holdings (HRC) United States $6.788B 20.24
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.231B 27.02
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.753B 0.00
NuVasive (NUVA) United States $3.507B 27.96
Neogen (NEOG) United States $3.413B 57.10
ICU Medical (ICUI) United States $3.189B 20.69
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.674B 0.00
Quidel (QDEL) United States $2.537B 25.19
Agios Pharmaceuticals (AGIO) United States $1.964B 0.00
National Vision Holdings (EYE) United States $1.818B 39.24
Cardiovascular Systems (CSII) United States $1.698B 0.00
Aphria (APHA) $1.215B 0.00
VAREX IMAGING (VREX) United States $1.119B 25.79
AtriCure (ATRC) United States $1.026B 0.00
Phibro Animal Health (PAHC) United States $0.871B 14.17
Eagle Pharmaceuticals (EGRX) United States $0.852B 21.73
Omeros (OMER) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.752B 0.00
PetIQ (PETQ) United States $0.731B 17.26
Lantheus Holdings (LNTH) United States $0.722B 18.97
Cerus (CERS) United States $0.630B 0.00
Surmodics (SRDX) United States $0.603B 114.61
MacroGenics (MGNX) United States $0.556B 0.00
TG Therapeutics (TGTX) United States $0.524B 0.00
OraSure Technologies (OSUR) United States $0.505B 23.37
Quanterix (QTRX) United States $0.500B 0.00
Owens & Minor (OMI) United States $0.455B 13.64
Meridian Bioscience (VIVO) United States $0.426B 13.31
Utah Medical Products (UTMD) United States $0.365B 26.75
Zynex (ZYXI) United States $0.353B 37.52
BioLife Solutions (BLFS) United States $0.344B 105.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.317B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.133B 0.00
Fonar (FONR) United States $0.131B 9.17
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.086B 20.37
Nephros (NEPH) United States $0.075B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.038B 0.00
Senestech (SNES) United States $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00